Key performance indicators for clinical pharmacy services in New Zealand public hospitals: Stakeholder perspectives

Journal of Pharmaceutical Health Services Research

Volumn 1, Issue 2, 2010, Pages 75-84

  Ng, Jerome ^a   Harrison, Jeff ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Benchmark; Clinical pharmacy; Hospital; Performance; Performance measures; Pharmacist interventions

Indexed keywords

ARTICLE; CLINICAL PHARMACY; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE SURVEY; MEDICAL RECORD REVIEW; MEDICATION ERROR; NEW ZEALAND; PATIENT CARE; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; PUBLIC HOSPITAL; STATISTICAL SIGNIFICANCE; TERTIARY HEALTH CARE;

EID: 79953762350     PISSN: 17598885     EISSN: 17598893     Source Type: Journal    
DOI: 10.1111/j.1759-8893.2010.00001.x     Document Type: Article

References (53)

1. Bates D et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA 1995; 274: 29-34.
2. Davis P et al. Adverse events in New Zealand public hospitals I: occurrence and impact. J NZ Med Assoc 2002; 115: U271.
3. Brown P et al. Cost of medical injury in New Zealand: a retrospective cohort study. J Health Serv Res Policy 2002; 7(S1): 29-34.
4. Ministry of Health. Towards a New Zealand Medicines Strategy. Wellington: Ministry of Health, 2006.
5. The Quality Improvement Committee. Sentinel and Serious Events in New Zealand Hospitals 2007-2008. Wellington: The Quality Improvement Committee, 2009.
6. Kaboli P et al. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 2006; 166: 955-964.
7. Schumock G et al. American College of Clinical Pharmacy; Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy 2003; 23: 113-132.
8. Bond C, Raehl C. Clinical Pharmacy services, pharmacy staffing and hospital mortality rates. Pharmacotherapy 2007; 27: 481-493.
9. Hepler C, Strand L. Opportunities and responsibilities in pharmaceutical care. American J Hosp Pharm 1990; 47: 533-543.
10. Stowasser D et al. Understanding the medicines management pathway. J Pharm Pract Res 2004; 34: 293-296.
11. SHPA. Society of Hospital Pharmacists of Australia; Standards of Practice for Clinical Pharmacy. J Pharm Pract Res 2005; 35: 122-146.
12. NZ Healthcare Pharmacists Association. Clinical Pharmacy Guidelines. Wellington: NZ Healthcare Pharmacists Association, 2007.
13. Fowler A, Campbell D. Benchmarking and performance management in clinical pharmacy. Int J Operations Productions Manag 2001; 21: 327-350.
14. Calvert R. Clinical pharmacy - a hospital perspective. Br J Clin Pharmacol 1999; 47: 231-238.
15. Millar T et al. Document pharmacist's clinical interventions in New Zealand Hospitals. Pharm World Sci 2008; 30: 99-106.
16. Ng J. There's no 'I' in team but there's a me. Pharm J NZ 2008: 3.
17. Dooley M et al. Multicentre pilot study of a standard approach to document clinical pharmacy activity. Austr J Hosp Pharm 2000; 30: 150-155.
18. Scally G, Donaldson L. Clinical governance and the drive for quality improvement in the new NHS in England. BMJ 1998; 317: 61-65.
19. Delaney T. Can clinical pharmacy services be justified if they cannot be measured? Irish Pharm J 1999; 77: 232-233, 235-237.
20. Majeed F, Voss S. Performance indicators for general practice. BMJ 1995; 311: 209-210.
21. Lauver L. Benchmarking: improving outcomes for the congestive heart failure population. J Nurs Care Qual 1996; 10: 7-11.
22. Bergman R. Hitting the mark. Hosp Health Netw 1994; 68: 48.
23. Mosel D, Gift B. Collaborative benchmarking in health care. Jt Comm J Qual Improv 1994; 20: 239-249.
24. Camp R, Tweet A. Benchmarking applied to health care. Jt Comm J Qual Improv 1994; 20: 229-238.
25. Bright J, Tenni P. Clinical services documentation (CSD) system for documenting clinical pharmacists' services. Aust J Hosp Pharm 2000; 301: 10-15.
26. Bhavnani S. Benchmarking in health-system pharmacy: current research and practical applications. Am J Health Syst Pharm 2000; 57(Suppl 2): S13-S20.
27. Kim Y, Schepers G. Pharmacist intervention documentation in US health care systems. Hosp Pharm 2003; 38: 1141-1147.
28. Rifenburg R et al. Benchmark analysis of strategies hospitals use to control antimicrobial expenditures. Am J Health-Syst Pharm 1996; 53: 2054-2062.
29. Mackinnon G, Mackinnon N. In: DiPirio J et al., eds, Pharma-cotherapy - A pathophysiologic approach: Documentation of Pharmacy Services. 7th edn. Columbia: McGraw Hill, 2008: 7.
30. Gupta S et al. Monitoring of pharmacy staffing, workload, and productivity in community hospitals. Am J Health-Syst Pharm 2006; 63: 1728-1734.
31. Society of Hospital Pharmacists Association. Standards of Practice for Clinical Pharmacy. J Pharm Pract Res 2005; 35: 122-146.
32. American Society of Health System Pharmacist (2009). A Crosswalk Linking National Quality Indicators with National Organizations, Legislation, and Clinical Practice Guidelines Supporting Use of the Indicators. American Society of Health System Pharmacist. www.ashp.org/s_ashp/docs/files/QII_Crosswalk062907.pdf (accessed 1 March 2009).
33. NSW Therapeutic Advisory Group (2007). Indicators for Quality Use of Medicines in Australian Hospitals. NSW Therapeutic Advisory Group. www.cec.health.nsw.gov.au/currentprojects.html#pims (accessed 2 May 2008).
34. Griffin F, Resar R. IHI Global Trigger Tool for Measuring Adverse Events. IHI Innovation Series White Paper. Cambridge, MA: Institute for Healthcare Improvement, 2007.
35. Institute for Healthcare Improvement. 5 Million Lives Campaign. Getting Started Kit: Preventing Harm from High-Alert Medications. Cambridge, MA: Institute for Healthcare Improvement, 2008.
36. Brudon P et al. Indicators for Monitoring National Drug Policies - A Practical Manual, 2nd edn. Geneva: World Health Organization, 1999.
37. Institute of Healthcare Improvement. Getting Started Kit: Prevent Adverse Drug Events (Medication Reconciliation) How To Guide. Cambridge, MA: Institute for Healthcare Improvement, 2006.
38. Rozich J, Resar R. Medication safety: one organization's approach to the challenge. J Clin Outcomes Manage 2001; 810: 27-34.
39. Michels R, Meisel S. Program using pharmacy technicians to obtain medication histories. Am J Health-Syst Pharm 2003; 60: 1982-1986.
40. Horsburgh M et al. The professional subcultures of students entering medicine, nursing and pharmacy programmes. J Interprof Care 2006; 204: 425-431.
41. Degeling P et al. A comparison of the impact of hospital reform on medical subcultures in some Australian and New Zealand Hospitals. Aust Health Rev 1999; 22: 172-188.
42. Degeling P et al. A cross-national study of differences in the identities of nursing in England and Australia and how this has affected nurses' capacity to respond to hospital reform. Nurs Inquiry 2000; 7: 120-135.
43. Degeling P et al. Medicine, management and modernisation: a danse macabre. BMJ 2003; 326: 649-652.
44. Kaushal R et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001; 285: 2114-2120.
45. Thielke T, Stirm E. PharmaTrend as a management tool: implementation in a university hospital. Am J Hosp Pharm 1989; 46: 2019-2022.
46. Bindman A et al. Diagnostic scope of and exposure to primary medical care in Australia, New Zealand, and the United States: results from three national surveys. BMJ 2007; 334: 1261.
47. Cousins D et al. Reliability and validity of hospital pharmacists clinical intervention data. Am J Health-Syst Pharm 1997; 54: 1596-1603.
48. Forman D, Nyatanga L. The evolution of shared learning: some political and professional imperatives. Med Teacher 1999; 2: 489-496.
49. World Health Organization. Learning to Work Together: Report of a WHO Study Group on Multiprofessional Education for Health Personnel. 1998 Team Approach Technical Report Series. Geneva: World Health Organization, 1998.
50. Eddy D. Performance measurement: problems and solutions. Health Affairs 1998; 17: 7-25.
51. Smith P. On the unintended consequences of publishing performance data in the public sector. Int J Public Admin 1995; 18: 277-310.
52. Majeed A et al. Improving the quality of care with performance indicators. BMJ 2007; 335: 916-918.
53. Sheldon T. Promoting health care quality: what role performance indicators? Qual Health Care 1998; 7(Suppl.): S45-S50.